The scleromyositis phenotype. Lessons from a multicentre international cohort of anti-PM/Scl-positive patients

Rheumatology (Oxford). 2021 Nov 3;60(11):4956-4957. doi: 10.1093/rheumatology/keab433.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Autoantibodies*
  • Cohort Studies
  • Humans
  • Phenotype

Substances

  • Autoantibodies